[Asthma, allergy, current aspects. Report of the first Genevan 3A. Asthma: from biology to clinical aspects].
Polla
B S
BS
Russo-Marie
F
F
Lockhart
A
A
Moneret-Vautrin
D A
DA
Emmenegger
V
V
Junod
A
A
Dusser
D
D
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D017302:Annexins; D001249:Asthma / Q000139:chemically induced / Q000188:drug therapy / Q000378:metabolism*; D002135:Calcium-Binding Proteins / Q000096:biosynthesis; D005503:Food Additives / Q000009:adverse effects; D006801:Humans; D010740:Phospholipases / Q000037:antagonists & inhibitors; D012130:Respiratory Hypersensitivity / Q000378:metabolism*; D013447:Sulfites / Q000009:adverse effects
D000305:Adrenal Cortex Hormones; D017302:Annexins; D002135:Calcium-Binding Proteins; D005503:Food Additives; D013447:Sulfites; C030981:metabisulfite; D010740:Phospholipases
Asthme, allergie, actualités. Compte rendu des premiers 3A genevois. Asthme: de la biologie à la clinique.